Evidence map›Paper›PMID 27893430›Full record

ArticleOncotarget2016

KIAA0247 suppresses the proliferation, angiogenesis and promote apoptosis of human glioma through inactivation of the AKT and Stat3 signaling pathway.

Ying Tan, Ning Huang, Xiang Zhang, Jiangang Hu, Si Cheng, Li Pi, Yuan Cheng

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. miR-451 suppresses EMT and metastasis in glioma cells.Cell cycle (Georgetown, Tex.) · 2021
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ying TanDepartment of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Ning HuangDepartment of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xiang ZhangDepartment of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jiangang HuDepartment of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Si ChengDepartment of Orthopaedics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Li PiDepartment of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yuan ChengDepartment of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Dalian Medical University · CNSecond Affiliated Hospital of Chongqing Medical University · CNChongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gliomas are the most common and aggressive type of primary adult brain tumors. Although KIAA0247 previously is a speculated target of the tumor suppressor gene, little is known about the association between KIAA0247 and glioma. In this study, we clearly demonstrate that KIAA0247 expression is decreased in glioma and was negatively correlated with the histologic grade. Overexpression of KIAA0247 in glioma cells inhibits proliferation, angiogenesis and promoted apoptosis of human glioma cells in vitro. In contrast, knockdown of KIAA0247 increases the proliferation, angiogenesis and decreases apoptosis of these cells. In a tumor xenograft model, overexpression of KIAA0247 suppresses tumor growth of glioma cells in vivo, while KIAA0247 knockdown promotes the tumor growth. Mechanistically, overexpression of KIAA0247 is able to inhibit phosphorylation of AKT and Stat3 in glioma cells, resulting in inactivation of the AKT and Stat3 signaling pathways, this ultimately decreases the expression of PCNA, CyclinD1, Bcl2 and VEGF. Collectively, these data indicate that KIAA0247 may work as a tumor suppressor gene in glioma and a promising therapeutic target for gliomas.

Indexed as

ApoptosisAnimalsBrain NeoplasmsCell Line, TumorCell ProliferationComplement System ProteinsGliomaHumansMaleMembrane ProteinsMiceNeovascularization, PathologicPhosphorylationProto-Oncogene Proteins c-aktSignal TransductionSTAT3 Transcription FactorComplement System ProteinsMembrane ProteinsProto-Oncogene Proteins c-aktSTAT3 Transcription FactorSUSD6 protein, humanTumor Suppressor Proteinsangiogenesiscell apoptosiscell proliferationgliomaKIAA0247

Identifiers

PMID27893430
PMCPMC5349974
OpenAlexW2554470241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.